MUC5AC and asthma: While T2 cytokines may make an important contribution to ongoing mucus production in T2‐high asthma and provide another mechanism through which anti‐IL4Rα therapy may work to reduce asthma exacerbations, further work is required to establish the many possible factors driving persistent MUC5AC expression in T2‐low asthma.